Midwest Equine

Feature Article

AAEP Guidelines for the Vaccination of Foals

ArticleJanuary 2016
AAEP Guidelines for the Vaccination of Foals

AAEP Vaccination of Foals Guidelines

According to the American Association of Equine Practitioners (AAEP), the two categories below reflect differences in the foal's susceptibility to disease and ability to mount an appropriate immune response to vaccination. The foal's response is based on the presence (or absence) of maternal antibodies derived from colostrum.

To learn more and read about recommended dosages, visit the AAEP's website: www.aaep.org

Core Vaccinations
Protect against diseases that are:

  • Endemic to a region
  • A potential public health significance
  • Required by law
  • Virulent/highly infectious
  • Pose a risk of severe disease

Core vaccines have clearly demonstrated efficacy and safety, and thus exhibit a high enough level of patient benefit and low enough level of risk to justify their use in all equids.

Include the following diseases:

  • Tetanus
  • Eastern/Western Equine Encephalomyelitis (EEE/WEE)
  • Rabies
  • West Nile Virus (WNV)

Risk-based Vaccinations

  • Vary between individuals, populations, and geographic regions
  • Should require a consultation with a licensed veterinarian to identify appropriate vaccines

Include the following diseases:

  • Anthrax
  • Equine Herpesvirus (EHV)
  • Equine Viral Arteritis (EVA)
  • Equine Influenza
  • Potomac Horse Fever (PHF)
  • Rotavirus
  • Strangles Streptococcus equi

These guidelines are intended to be a reference used by veterinarians utilizing vaccines in their respective practices. They are neither regulations nor directives and should not be interpreted as such. It is the responsibility of attending veterinarians, through an appropriate veterinarian-client-patient relationship, to utilize relevant information coupled with product availability to determine optimal health care programs for their patients.

Source "Vaccination Guidelines." AAEP.
http://www.aaep.org/info/vaccination-guidelines-265 (accessed October 31, 2014).